Grover Michael L, Bracamonte Jesse D, Kanodia Anup K, Edwards Frederick D, Weaver Amy L
Department of Family Medicine, Mayo Clinic College of Medicine, 13737 North 92nd Street, Scottsdale, AZ 85260, USA.
J Am Board Fam Med. 2009 May-Jun;22(3):266-71. doi: 10.3122/jabfm.2009.03.080123.
We were interested to know if our older female patients with urinary tract infections (UTIs) might have differing pathogens or rates of Escherichia coli antibiotic sensitivity and if our physicians managed them in a manner similar or dissimilar to the care provided to younger patients with no complications.
This was a secondary analysis from patients excluded from a previous retrospective study regarding uncomplicated UTIs.
Twenty-six percent of total patients with UTIs were older than 65 and otherwise medically uncomplicated whereas 21% were older patients who did have complicating factors. E. coli was a pathogen in 81% of uncomplicated elders' and 54% of complicated elders' cultures. E. coli sensitivity rate to sulfamethoxazole-trimethoprim (SMX/TMP) in both groups was 86%. Physicians were significantly less likely to prescribe SMX/TMP for complicated older patients with complications than for young patients with an uncomplicated UTI (P = .017); there was a significant trend of physicians to be less likely to prescribe SMX/TMP with advancing age in a patient and complications across all 3 groups (P = .011). Antibiotics rarely needed to be changed after cultures.
The presence of E. coli on culture in patients with a UTI changes based on medical complications, not age. Being medically complex did not result in reduced sensitivity of E. coli to SMX/TMP but was associated with increased rates of the presence of other pathogens. In our setting, treatment employed with SMX/TMP and without the use of culture and sensitivity may be effective for appropriately selected older women. Prospective studies are needed to determine the optimal approach to management.
我们想了解老年女性尿路感染(UTI)患者是否有不同的病原体或大肠杆菌抗生素敏感性发生率,以及我们的医生对她们的治疗方式与对无并发症的年轻患者的治疗方式是否相似或不同。
这是对先前一项关于单纯性UTI的回顾性研究中排除的患者进行的二次分析。
UTI患者中26%年龄超过65岁且无其他医学并发症,而21%是有并发症的老年患者。大肠杆菌是81%的无并发症老年患者和54%的有并发症老年患者培养物中的病原体。两组中大肠杆菌对磺胺甲恶唑-甲氧苄啶(SMX/TMP)的敏感率均为86%。与无并发症的年轻UTI患者相比,医生为有并发症的老年患者开具SMX/TMP的可能性显著降低(P = 0.017);在所有三组患者中,随着患者年龄增长和出现并发症,医生开具SMX/TMP的可能性有显著降低的趋势(P = 0.011)。培养后很少需要更换抗生素。
UTI患者培养物中大肠杆菌的存在情况因医学并发症而异,而非年龄。病情复杂并不会导致大肠杆菌对SMX/TMP的敏感性降低,但与其他病原体存在率增加有关。在我们的研究环境中,对于适当选择的老年女性,使用SMX/TMP且不进行培养和药敏试验的治疗可能有效。需要进行前瞻性研究以确定最佳的管理方法。